Muscle-invasive bladder cancer (MIBC) is bladder cancer that has grown into the main muscle layer of the bladder. Some people are diagnosed with MIBC after having non-muscle-invasive bladder cancer (NMIBC). Others have MIBC when they’re first diagnosed.
Learning that bladder cancer is muscle-invasive can feel frightening. Understanding what each stage means can help you and your care team plan your care and discuss the path forward.
One member of MyBladderCancerTeam recently learned their NMIBC had progressed to MIBC. “Once my results from my biopsy come in and we learn my stage, I feel confident that my urologist and oncologist can help me make the right decisions,” they wrote.
Here’s what each stage means and how staging may help guide your care and treatment discussions.
MIBC is most often staged using the TNM staging system. In this system, each letter stands for a piece of information to help determine the stage, as follows:
Letters and numbers placed after T, N, and M provide more details about the cancer. In general, higher numbers mean the cancer is more advanced in that category.
For example, you may see TNM written like this: T2, N0, M0. This means the tumor has grown into the detrusor (bladder muscle), but cancer has not been found in nearby lymph nodes or distant parts of the body.
If you see an X, such as TX or NX, it means that part of the cancer couldn’t be assessed because there wasn’t enough information.
The TNM categories are combined to determine an overall stage through a process called a stage grouping. The stage describes how far the cancer has grown or spread and helps guide treatment discussions.
Stage groupings range from stage 0 to stage 4. Cancer stages are sometimes written with Roman numerals, such as stage III instead of stage 3.
In general, a lower number (earlier stage) means the cancer has grown or spread less, while a higher number (or later stage) means it is more advanced.
MIBC begins at stage 2 because the cancer has grown into the bladder muscle.
Below are the stages of MIBC. You’ll notice that MIBC starts at stage 2. Stages 0 and 1 are considered non-muscle-invasive bladder cancer because the cancer has not grown into the bladder’s muscle layer.
In stage 0, the cancer is limited to the bladder’s inner lining and has not grown into the connective tissue or muscle.
In stage 1, the cancer has grown into the connective tissue under the bladder lining, but it has not reached the muscle layer.
Read our guide on the difference between NMIBC and MIBC to learn more.
Stage 2 (T2, N0, M0) means the cancer has grown through the bladder lining and connective tissue into the bladder muscle. Cancer has not been found in nearby lymph nodes or distant parts of the body.
The five-year relative survival rate for localized bladder cancer — cancer that has not spread outside the bladder — is about 73 percent. This number is not specific to stage 2.
A five-year relative survival rate compares people with bladder cancer with similar people who don’t have bladder cancer and describes how likely they are to be alive five years after diagnosis.
Survival rates are estimates based on large groups of people. They cannot predict one person’s outcome. Your outlook may also depend on:
At stage 2, your doctor may recommend a radical cystectomy, which is surgery to remove the entire bladder, nearby lymph nodes, and sometimes nearby organs or tissues. During the surgery, your doctor will create a urinary diversion — a new way for urine to leave your body.
People who choose surgery may also receive systemic treatment before surgery, after surgery, or both. Systemic treatment travels through the bloodstream to reach cancer cells throughout the body. Options may include cisplatin-based chemotherapy or newer combinations of immunotherapy and other cancer drugs.
If you can’t undergo surgery or decide against it after discussing the benefits and risks with your care team, your doctor may suggest bladder-preserving treatment that combines chemotherapy with external-beam radiation therapy.
External-beam radiation therapy uses high-energy beams from outside the body to destroy cancer cells. Chemotherapy given at the same time can help the radiation work better.
Stage 3A means the cancer has grown outside the bladder muscle or spread to one nearby lymph node. It has two possible TNM stages:
Treatment may include some of the same approaches used for stage 2, such as surgery, chemotherapy, immunotherapy, or chemoradiation. For some people, treatment may include cisplatin-based chemotherapy before surgery, followed by immunotherapy after surgery.
The recommended approach depends on the tumor’s location, lymph node involvement, overall health, and treatment goals.
Stage 3B (T1 through T4a, N2 or N3, M0) also means the cancer may have grown beyond the muscle, like stage 3A, but it now involves two or more lymph nodes in the pelvis or at least one lymph node near major blood vessels in the pelvis. The cancer hasn’t spread to distant parts of the body.
Treatment may include surgery, chemotherapy, immunotherapy, or chemoradiation, depending on whether the cancer can be removed and the person’s overall health. For some eligible people, treatment may include cisplatin-based chemotherapy before surgery, followed by immunotherapy after surgery.
The five-year relative survival rate for regional bladder cancer is about 41 percent. This estimate includes, but is not limited to, stage 3 cancer and cannot predict an individual person’s outcome.
Stage 4A is a form of advanced bladder cancer. It has two possible TNM stages:
Treatment for stage 4A may include:
Stage 4B bladder cancer — any T, any N, M1b — is considered metastatic and the most advanced stage. Stage 4B is different from stage 4A because it has spread to distant organs, such as the lungs, bones, or liver.
Once bladder cancer spreads to distant areas of the body, the five-year relative survival rate is about 9 percent. The goal of treatment for this stage is to slow or stop the cancer from growing, ease symptoms, and improve quality of life.
Treatment for stage 4B may include:
MIBC stages generally describe how far the cancer has grown through the bladder wall and whether it has spread to nearby organs, lymph nodes, local organs, or other parts of the body. The stage may help explain some symptoms, but symptoms alone cannot show whether the cancer has grown or spread.
For instance, one MyBladderCancerTeam member was diagnosed with stage 2 MIBC and wasn’t sure if pelvic pain was expected. “I’m scared my cancer is growing overnight. Is it normal to have pain at this stage?” they wrote.
A doctor can help explain possible causes of new or worsening symptoms and which changes need prompt attention.
The clinical stage can also help you and your healthcare team determine which treatment options may be appropriate. However, the right treatment option for MIBC also depends on your:
Doctors assign a clinical stage to MIBC based on the results of several tests, including:
If you’ve already received surgery to partially or completely remove your bladder, your healthcare team may also study the tissue to assign a pathological stage. A pathological stage may provide more detailed information because the tissue can be examined directly to show how far the cancer has grown or spread.
Because pathological staging requires surgery, clinical staging is more commonly used before treatment to help guide decisions.
To better understand what your MIBC stage means for you, talk with your oncologist (a doctor who treats cancer). They can explain your symptoms, test results, treatment options, and what may affect your outlook.
Your oncologist can also connect you with support resources to help you cope with a challenging diagnosis. It’s OK to ask your care team for help.
On MyBladderCancerTeam, people share their experiences with bladder cancer, get advice, and find support from others who understand.
What stage of MIBC are you? What treatments are you undergoing? Let others know in the comments below.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.